ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Sigal Charles Elliott โ Director
Shares
1,600
Price
$152.25
Total Value
$243,600.00
P&L
+2.9% (+$7,040.00)
Nearby Earnings
Oct 29, 2026
EPS:Est: 1.75
Revenue:Est: $1.42B
Transaction Details
| Insider | Sigal Charles Elliott |
|---|---|
| Title | Director |
| Transaction Date | Nov 10, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | by Trust |
| Filing Date | Nov 12, 2026 |
| Shares Purchased | 1,600 |
| Price per Share | $152.25 |
| Total Value | $243,600.00 |
| Shares Owned After | 3,600 |
| Derivative | No |
| Accession Number | 0001178670-26-000087 |
| Document | View SEC Filing |